Viewing Study NCT04056403


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-31 @ 2:48 AM
Study NCT ID: NCT04056403
Status: UNKNOWN
Last Update Posted: 2019-08-14
First Post: 2019-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ultrasound Evaluation of Labor Epidural
Sponsor: National Taiwan University Hospital
Organization:

Study Overview

Official Title: The Use of Ultrasound to Evaluate Precision and Analgesic Efficacy of Labor Epidural Analgesia
Status: UNKNOWN
Status Verified Date: 2019-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To compare the labor epidural analgesic (EA) profiles between landmark insertion EA levels which are congruent and ingruent to ultrasound confirmation in lateral decubitus position.
Detailed Description: Epidural analgesia is the mainstream method for labor analgesia. Landmark identification of L3 to L5 spinous process is most commonly applied for determination of epidural insertion. However, the precision of epidural catheter insertion site was affected by physiological and anatomical variations in pregnant women and positions such as sitting or lateral decubitus. Previous study showed the clinical estimation would be ≥ 1 vertebral level higher than the anatomical position determined by ultrasound at least 40% of the time in sitting position among western pregnant women. For asian parturients, epidural analgesia is commonly performed in lateral decubitus position because of smaller stature. In addition, it remains uncertain whether the landmark epidural insertion level congruent or ingruent is associated with different analgesia profiles such as the dosage requirement and the frequncy of adjustment.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: